查詢結果分析
相關文獻
- 肺癌口服標靶治療常見皮膚副作用
- 表皮生長因子接受器酪胺酸酶抑制劑於晚期肺癌治療
- 抑制劑Benzaldehyde-O-alkyloximes對酪胺酸酶活性抑制QSAR模型
- 臺灣嘉寶果萃取及分離物之化妝品活性評估
- 蕃茄萃取物抑制酪胺酸酶活性作用
- Critical Appraisal of Gefitinib in the Treatment of Non-Small Cell Lung Cancer
- Pulmonary Squamous Cell Carcinoma Harboring EGFR Exon 19 Mutation Responded Dramatically to EGFR-TKI--A Case Report
- 淺談標靶藥物Cabozantinib造成的相關皮膚副作用
- 進展性非小細胞肺癌標靶治療新趨勢
- Patients Who Previously Responded to EGFR-TKI Treatment with Progression Responded to a Second EGFR-TKI Treatment after Challenge with Chemotherapy
頁籤選單縮合
題名 | 肺癌口服標靶治療常見皮膚副作用=Common Cutaneous Adverse Effects Associated with Oral Targeted Therapy for Lung Cancer |
---|---|
作者姓名(中文) | 蔡騰輝; 李怡萱; 林育昰; 林佩姿; | 書刊名 | 藥學雜誌 |
卷期 | 36:2=143 2020.06[民109.06] |
頁次 | 頁72-78 |
分類號 | 418.31 |
關鍵詞 | 表皮生長因子受體抑制劑; 皮膚副作用; 酪胺酸酶抑制劑; Epidermal growth factor receptor inhibitors; Skin adverse effects; Tyrosine kinase inhibitors; |
語文 | 中文(Chinese) |